Combined treatment with oral etretinate and electron beam therapy in patients with cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
- 1 June 1992
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 26 (6) , 960-967
- https://doi.org/10.1016/0190-9622(92)70142-3
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphomaJournal of the American Academy of Dermatology, 1989
- Topical mechiorethamine therapy for early stage mycosis fungoidesJournal of the American Academy of Dermatology, 1988
- Combined modality therapy for tumor stage mycosis fungoides: results of a 10-year follow-up.Journal of Clinical Oncology, 1988
- PUVA Treatment of Erythrodermic and Plaque-Type Mycosis FungoidesArchives of Dermatology, 1987
- Recombinant interferon alfa-2a, an active agent in advanced cutaneous t-cell lymphomasInternational Journal of Cancer, 1987
- Treatment of Cutaneous T-Cell LymphomaDermatologic Clinics, 1985
- Total skin electron beam irradiation for cutaneous T-cell lymphoma (mycosis fungoides)British Journal of Dermatology, 1985
- An investigation of 2'-deoxycoformycin in the treatment of cutaneous T- cell lymphomaBlood, 1983
- Cutaneous T-cell lymphoma: clinicopathological relationships, therapy and survival in ninety-two patientsBritish Journal of Dermatology, 1982
- Treatment of Mycosis FungoidesArchives of Dermatology, 1982